Clinical Science
Efficacy of Retinal Lesion Screening in Von Hippel-Lindau Patients With Widefield Color Fundus Imaging Versus Widefield FA
Abstract
BACKGROUND AND OBJECTIVE:
Retinal hemangioblastoma is a retinal tumor in patients with Von Hippel-Lindau (VHL). The authors' objective was to determine whether widefield fluorescein angiography (FA) improves lesion detection.
PATIENTS AND METHODS:
Retrospective case series of VHL patients who underwent widefield fundus imaging and FA. Masked retina specialists graded fundus images as having: 1) definite retinal hemangioblastoma; 2) possible lesion; 3) no lesion. The number of lesions on FA was compared to widefield color imaging.
RESULTS:
One hundred six eyes of 55 patients were evaluated. A total of 94 lesions were identified on FA in 61.8% patients. Forty-three lesions (45.7%) were not identified on fundus images. Small lesion detection was significantly higher with FA compared to color imaging (P = .013).
CONCLUSIONS:
This study reports on improved detection of retinal hemangioblastomas with widefield FA compared to widefield fundus images. The authors recommend VHL monitoring guidelines to include periodic widefield FA to adequately screen for smaller lesions.
[Ophthalmic Surg Lasers Imaging Retina. 2019;50:e260–e265.]
- 1.Frantzen C, Klasson T, Links T, Von Hippel-Lindau Syndrome. In: , eds. GeneReviews. [Internet] Seattle, WA: University of Washington; 2000. [last updated 2015] Google Scholar
- 2.Maher ER, Neumann HP, Richard S. von Hippel-Lindau disease: a clinical and scientific review. Eur J Hum Genet. 2011; 19(6):617–623.
DOI:
https://doi.org/10.1038/ejhg.2010.175 PMID:
10.1038/ejhg.2010.175 21386872 Crossref Medline, Google Scholar - 3.Latif F, Tory K, Gnarra J, Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 1993; 260(5112):1317–1320.
DOI:
https://doi.org/10.1126/science.8493574 PMID:
10.1126/science.8493574 8493574 Crossref Medline, Google Scholar - 4.Maddock IR, Moran A, Maher ER, A genetic register for von Hippel-Lindau disease. J Med Genet. 1996; 33(2):120–127.
DOI:
https://doi.org/10.1136/jmg.33.2.120 PMID:
10.1136/jmg.33.2.120 8929948 Crossref Medline, Google Scholar - 5.Maher ER, Iselius L, Yates JR, Von Hippel-Lindau disease: a genetic study. J Med Genet. 1991; 28(7):443–447.
DOI:
https://doi.org/10.1136/jmg.28.7.443 PMID:
10.1136/jmg.28.7.443 1895313 Crossref Medline, Google Scholar - 6.Dollfus H, Massin P, Taupin P, Retinal hemangioblastoma in von Hippel-Lindau disease: a clinical and molecular study. Invest Ophthalmol Vis Sci. 2002; 43(9):3067–3074. PMID:
12202531 Medline, Google Scholar - 7.Maher ER, Yates JR, Harries R, Clinical features and natural history of von Hippel-Lindau disease. Q J Med. 1990; 77(283):1151–1163.
DOI:
https://doi.org/10.1093/qjmed/77.2.1151 PMID:
10.1093/qjmed/77.2.1151 2274658 Crossref Medline, Google Scholar - 8.Singh AD, Shields CL, Shields JA. von Hippel-Lindau disease. Surv Ophthalmol. 2001; 46(2):117–142.
DOI:
https://doi.org/10.1016/S0039-6257(01)00245-4 PMID:
10.1016/S0039-6257(01)00245-4 11578646 Crossref Medline, Google Scholar - 9.Wong WT, Agrón E, Coleman HR, Clinical characterization of retinal capillary hemangioblastomas in a large population of patients with von Hippel-Lindau disease. Ophthalmology. 2008; 115(1):181–188.
DOI:
https://doi.org/10.1016/j.ophtha.2007.03.009 PMID:
10.1016/j.ophtha.2007.03.009 Crossref Medline, Google Scholar - 10.Singh AD, Nouri M, Shields CL, Shields JA, Perez N. Treatment of retinal capillary hemangioma. Ophthalmology. 2002; 109(10):1799–1806.
DOI:
https://doi.org/10.1016/S0161-6420(02)01177-6 PMID:
10.1016/S0161-6420(02)01177-6 12359597 Crossref Medline, Google Scholar - 11.Singh AD, Nouri M, Shields CL, Shields JA, Smith AF. Retinal capillary hemangioma: a comparison of sporadic cases and cases associated with von Hippel-Lindau disease. Ophthalmology. 2001; 108(10):1907–1911.
DOI:
https://doi.org/10.1016/S0161-6420(01)00758-8 PMID:
10.1016/S0161-6420(01)00758-8 11581072 Crossref Medline, Google Scholar - 12.Toy BC, Agrón E, Nigam D, Chew EY, Wong WT. Longitudinal analysis of retinal hemangioblastomatosis and visual function in ocular von Hippel-Lindau disease. Ophthalmology. 2012; 119(12):2622–2630.
DOI:
https://doi.org/10.1016/j.ophtha.2012.06.026 PMID:
10.1016/j.ophtha.2012.06.026 22906772 Crossref Medline, Google Scholar - 13.Kreusel KM, Bechrakis NE, Krause L, Neumann HP, Foerster MH. Retinal angiomatosis in von Hippel-Lindau disease: a longitudinal ophthalmologic study. Ophthalmology. 2006; 113(8):1418–1424.
DOI:
https://doi.org/10.1016/j.ophtha.2006.02.059 PMID:
10.1016/j.ophtha.2006.02.059 16769118 Crossref Medline, Google Scholar - 14.Alliance VHLVHLA Suggested Active Surveillance Guidelines (5/20/2016). https://www.vhl.org/wp-content/uploads/2017/07/Active-Surveillance-Guidelines.pdf. Accessed on October 1, 2017. Google Scholar
- 15.Witmer MT, Kiss S. Wide-field imaging of the retina. Surv Ophthalmol. 2013; 58(2):143–154.
DOI:
https://doi.org/10.1016/j.survophthal.2012.07.003 PMID:
10.1016/j.survophthal.2012.07.003 23369515 Crossref Medline, Google Scholar - 16.Schoen MA, Shields CL, Say EAT, Douglass AM, Shields JA, Jampol LM. Clinically invisible retinal hemangioblastomas detected by spectral domain optical coherence tomography and fluorescein angiography in twins. Retin Cases Brief Rep. 2018; 12(1):12–16.
DOI:
https://doi.org/10.1097/ICB.0000000000000382 PMID:
10.1097/ICB.0000000000000382 Crossref Medline, Google Scholar - 17.Chen X, Sanfilippo CJ, Nagiel A, Early detection of retinal hemangionlastomas in Von Hippel-Lindau disease using ultra-widefield fluorescein angiography. Retina. 2018; 38(4):748–754.
DOI:
https://doi.org/10.1097/IAE.0000000000001601 PMID:
10.1097/IAE.0000000000001601 Crossref Medline, Google Scholar - 18.Meyer-Schwickerath G. The preservation of vision by treatment of intraocular tumors with light coagulation. Arch Ophthalmol. 1961; 66(4):458–466.
DOI:
https://doi.org/10.1001/archopht.1961.00960010460004 PMID:
10.1001/archopht.1961.00960010460004 14473182 Crossref Medline, Google Scholar - 19.Lane CM, Turner G, Gregor ZJ, Bird AC. Laser treatment of retinal angiomatosis. Eye (Lond). 1989; 3(Pt 1):33–38.
DOI:
https://doi.org/10.1038/eye.1989.5 PMID:
10.1038/eye.1989.5 Crossref Medline, Google Scholar - 20.Annesley WH, Leonard BC, Shields JA, Tasman WS. Fifteen year review of treated cases of retinal angiomatosis. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1977; 83(3 Pt 1):OP446–OP453. PMID:
888257 Medline, Google Scholar - 21.Schmidt D, Natt E, Neumann HP. Long-term results of laser treatment for retinal angiomatosis in von Hippel-Lindau disease. Eur J Med Res. 2000; 5(2):47–58. PMID:
10720563 Medline, Google Scholar - 22.Gorin MB. Von Hippel-Lindau disease: clinical considerations and the use of fluorescein-potentiated argon laser therapy for treatment of retinal angiomas. Semin Ophthalmol. 1992; 7(3):182–191.
DOI:
https://doi.org/10.3109/08820539209065107 PMID:
10.3109/08820539209065107 10147715 Crossref Medline, Google Scholar - 23.Kim H, Yi JH, Kwon HJ, Lee CS, Lee SC. Therapeutic outcomes of retinal hemangioblastomas. Retina. 2014; 34(12):2479–2486.
DOI:
https://doi.org/10.1097/IAE.0000000000000254 PMID:
10.1097/IAE.0000000000000254 25072649 Crossref Medline, Google Scholar - 24.Rosa RH, Goldberg MF, Green WR. Clinicopathologic correlation of argon laser photocoagulation of retinal angiomas in a patient with von Hippel-Lindau disease followed for more than 20 years. Retina. 1996; 16(2):145–156.
DOI:
https://doi.org/10.1097/00006982-199616020-00011 PMID:
10.1097/00006982-199616020-00011 8724960 Crossref Medline, Google Scholar - 25.Cho M, Kiss S. Detection and monitoring of sickle cell retinopathy using ultra wide-field color photography and fluorescein angiography. Retina. 2011; 31(4):738–747.
DOI:
https://doi.org/10.1097/IAE.0b013e3181f049ec PMID:
10.1097/IAE.0b013e3181f049ec 21836403 Crossref Medline, Google Scholar - 26.Wessel MM, Aaker GD, Parlitsis G, Cho M, D'Amico DJ, Kiss S. Ultra-wide-field angiography improves the detection and classification of diabetic retinopathy. Retina. 2012; 32(4):785–791.
DOI:
https://doi.org/10.1097/IAE.0b013e3182278b64 PMID:
10.1097/IAE.0b013e3182278b64 Crossref Medline, Google Scholar - 27.Kwiterovich KA, Maguire MG, Murphy RP, Frequency of adverse systemic reactions after fluorescein angiography. Results of a prospective study. Ophthalmology. 1991; 98(7):1139–1142.
DOI:
https://doi.org/10.1016/S0161-6420(91)32165-1 PMID:
10.1016/S0161-6420(91)32165-1 1891225 Crossref Medline, Google Scholar - 28.Kwan AS, Barry C, McAllister IL, Constable I. Fluorescein angiography and adverse drug reactions revisited: the Lions Eye experience. Clin Exp Ophthalmol. 2006; 34(1):33–38.
DOI:
https://doi.org/10.1111/j.1442-9071.2006.01136.x PMID:
10.1111/j.1442-9071.2006.01136.x 16451256 Crossref Medline, Google Scholar - 29.Yannuzzi LA, Rohrer KT, Tindel LJ, Fluorescein angiography complication survey. Ophthalmology. 1986; 93(5):611–617.
DOI:
https://doi.org/10.1016/S0161-6420(86)33697-2 PMID:
10.1016/S0161-6420(86)33697-2 3523356 Crossref Medline, Google Scholar - 30.Bearelly S, Rao S, Fekrat S. Anaphylaxis following intravenous fluorescein angiography in a vitreoretinal clinic: report of 4 cases. Can J Ophthalmol. 2009; 44(4):444–445.
DOI:
https://doi.org/10.3129/i09-068 PMID:
10.3129/i09-068 19606168 Crossref Medline, Google Scholar
